Imihimod (Imiquimodum)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Antiviral drugs (excluding HIV)

Other immunomodulators

Included in the formulation
  • ALDARA
    cream externally 
    R-PHARM, CJSC     Russia
  • Keravort
    cream externally 
    Glenmark Pharmaceuticals Co., Ltd.     India
    • АТХ:

    D.06.B.B.10   Imihimod

    Pharmacodynamics:

    Enhances the synthesis of endogenous α-interferon in the cells of the epithelium.

    Pharmacokinetics:

    The drug for topical application, systemic action on the body does not.

    Indications:

    It is used to treat genital warts in the perianal region and on the external genitalia.

    ICD-10

    I.A50-A64.A63.0   Anogenital (venereal) warts

    Contraindications:

    Individual intolerance, children under 18 years.

    Carefully:

    Hypersensitivity to the drug.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

    Dosing and Administration:

    The cream is applied externally 3 times a week before bedtime. The course of treatment continues until the disappearance of genital warts, but should not exceed 16 weeks.

    Side effects:

    Local dermatological reactions: itching, erythema, pain in places of application of cream.

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.
    Interaction:

    Not described.

    Special instructions:

    Apply only to affected areas.When treating, avoid exposure to sunlight to avoid sunburn.

    Instructions
    Up